title: Neurochemical and neurobehavioral effects of low lead exposure on the developing brain.
abstract: Lead is found in small but appreciable quantities in air, soil drinking water and food. Exposure to such amounts of lead does not cause acute lead toxicity, but produces subtle effects, particularly in children. The CDC advocates "safe" or "acceptable" levels of blood lead up to 10 μg/dl, while OSHA declares blood lead levels up to 40 μg/dl as "safe" or "acceptable" in the occupationally exposed. The objective of the study was to see if blood levels considered "safe" can cause changes in the biogenic neurotransmitters in the developing brain which may cause neurobehavioral defects like hyperactivity and other cognitive disorders. Albino Wistar rats were divided into the control and lead-treated groups. The control group was given unleaded water, while the lead-treated group was fed with 50 ppm lead acetate in drinking water. On day 45 the animals were subjected to a passive avoidance test, their blood analysed for ZPP and lead. They were then sacrificed and the neurotransmitters-Norepinephrine (NE) and its metabolite-methoxyhydroxyphenylglycol (MHPG) estimated in the brain areas associated with learning and memory-the frontal cortex, hippocampus and the striatum by HPLC-ECD. Our results showed significant increases in blood lead, NE and MHPG, while ZPP increase was insignificant. The rats showed neurobehavioral abnormalities as assessed by the passive avoidance test. We concluded that low blood levels of lead cannot be considered "safe" or "acceptable" as it causes neurotransmitter alterations. Increased NE turnover is implicated in hyperactivity disorders such as ADHD and Tourette syndrome.
authors.affiliation: Department of Biochemistry, St. John's National Academy of Health Sciences, Bengaluru, 560 034 India.
authors.forename: Anita R
authors.initials: AR
authors.lastname: Bijoor
authors.forename: S
authors.initials: S
authors.lastname: Sudha
authors.forename: T
authors.initials: T
authors.lastname: Venkatesh
keywords: Frontal cortex; Hippocampus; Lead; Neurobehavioral; Norepinephrine; Striatum
references.citation: Pharmacol Rev. 1985 Dec;37(4):333-64
references.pmid: 3915090
references.citation: Biochem Pharmacol. 1991 Feb 15;41(4):479-84
references.pmid: 1671748
references.citation: Lancet. 1972 Oct 28;2(7783):900-3
references.pmid: 4116603
references.citation: Science. 1975 Jan 31;187(4174):359-61
references.pmid: 1167426
references.citation: Learn Mem. 2009 Apr 29;16(5):308-14
references.pmid: 19403793
references.citation: J Neurosci. 2005 Mar 2;25(9):2322-9
references.pmid: 15745958
references.citation: J Lab Clin Med. 1978 Mar;91(3):366-76
references.pmid: 24077
references.citation: Environ Health Perspect. 2004 Jun;112(9):987-94
references.pmid: 15198918
references.citation: Br Med Bull. 1986 Oct;42(4):431-4
references.pmid: 3308000
references.citation: Cytobios. 2000;103(403):103-9
references.pmid: 11077972
references.citation: Annu Rev Neurosci. 1999;22:105-22
references.pmid: 10202533
references.citation: Obstet Gynecol Surv. 1992 May;47(5):285-9
references.pmid: 1570124
references.citation: J Neurochem. 1988 Feb;50(2):473-9
references.pmid: 2447240
references.citation: Arch Toxicol. 1990;64(4):305-14
references.pmid: 1974757
references.citation: Science. 1996 Aug 9;273(5276):749-50
references.pmid: 8701325
references.citation: Neurosci Lett. 1983 Sep 9;39(3):295-300
references.pmid: 6138739
references.citation: J Lab Clin Med. 1977 Apr;89(4):712-23
references.pmid: 557519
references.citation: Nature. 1987 Apr 16-22;326(6114):704-7
references.pmid: 3104800
references.citation: Environ Res. 1985 Oct;38(1):108-18
references.pmid: 4076100
references.citation: J ECT. 2001 Mar;17(1):41-4
references.pmid: 11281514